guess they bought the low 11's and made a killin
Most likely the institution that bought the offering at $11.25 a share, their aim it appears was to make profit fast and exit and not to wait for the uncertainties of FDA approval
uncertainties?!...whoa, that's heresy...professor, and everybody's uncle says it's a sure thing...$7 b-b-b-b=Billion market is at hand!....those guys are wuussies if they sell now!... heh professor?aloha,kamoa
oooops!...i think i know who dat is...ride 'em high...ride'em low..straddle'em...and watch'em...go go go!..hehhh, professor?aloha,kamoa
Hahaha, I don't own a single share. Options only. Did you get that script for lithium?